Ad
Friday, 7 June 2019
Unit of drugmaker Insys pleads guilty to U.S. opioid bribe scheme
A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment